Explain this page
Arphra AIPlain-English read on Huntington Bancshares Incorporated’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +98.13% | +87.61% | +64.02% | +58.23% | +61.70% | +62.53% | +62.67% | +61.80% |
| Operating margin | +26.17% | +34.77% | +22.12% | +20.09% | +21.53% | +21.22% | +21.16% | +21.21% |
| EBITDA margin | +32.60% | +40.86% | +29.52% | +25.29% | +21.53% | +24.96% | +25.67% | +25.86% |
| EBIT margin | +26.17% | +34.77% | +22.12% | +20.09% | +21.53% | +21.74% | +21.81% | +20.94% |
| Pre-tax margin | +26.17% | +34.77% | +22.12% | +20.09% | +21.53% | +21.55% | +21.05% | +21.22% |
| Net margin | +21.30% | +28.15% | +18.10% | +16.22% | +17.71% | +17.66% | +17.75% | +17.10% |
| Cost structure | ||||||||
| Cost of revenue / sales | +1.88% | +12.39% | +35.98% | +41.77% | +38.30% | +38.53% | +39.50% | +39.31% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +40.71% | +32.19% | +27.33% | +24.50% | +27.99% | +26.11% | +27.24% | +26.21% |
| Effective tax rate | +18.48% | +18.63% | +17.32% | +18.44% | +17.08% | +17.59% | +17.42% | +17.53% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | +6.70% | +12.59% | +10.06% | +9.81% | +9.07% | +9.90% | +9.80% | +9.61% |
| Return on assets (ROA) | +0.74% | +1.22% | +1.03% | +0.95% | +0.98% | +1.00% | +1.01% | +0.97% |
| Return on capital (ROC) | +5.95% | +9.38% | +7.36% | +6.61% | +6.27% | +6.75% | +6.75% | +6.71% |
| Return on invested capital (ROIC) | +4.84% | +7.59% | +6.02% | +5.34% | +5.16% | +5.62% | +5.66% | +5.41% |
| Asset turnover | +3.49% | +4.35% | +5.69% | +5.86% | +5.55% | +5.65% | +5.70% | +5.67% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +21.30% | +28.15% | +18.10% | +16.22% | +17.71% | +17.66% | +17.75% | +17.10% |
| Asset turnover (× revenue / assets) | +3.49% | +4.35% | +5.69% | +5.86% | +5.55% | +5.65% | +5.70% | +5.67% |
| Equity multiplier (× assets / equity) | +901.05% | +1029.35% | +976.22% | +1032.40% | +923.36% | +991.30% | +968.56% | +991.28% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 0.03 | 0.04 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Fixed-asset turnover | 5.22 | 6.88 | 9.72 | 11.22 | 9.45 | — | — | — |
| Inventory turnover | — | — | — | — | — | — | — | — |
| Receivables turnover | 0.97 | 1.17 | 1.58 | 1.58 | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 376.71 | 310.96 | 231.12 | 231.31 | — | — | — | — |
| Days inventory outstanding (DIO) | — | — | — | — | — | — | — | — |
| Days payables outstanding (DPO) | — | — | — | — | — | — | — | — |
| Cash conversion cycle | 376.71 | 310.96 | 231.12 | 231.31 | 0.00 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.59 | 1.80 | 1.36 | 0.94 | 1.15 | 1.11 | 1.13 | 1.17 |
| FCF / Net income | 1.40 | 1.70 | 1.29 | 0.86 | 1.03 | 1.07 | 1.03 | 1.06 |
| FCF margin | +29.85% | +47.96% | +23.35% | +13.98% | +18.25% | +18.88% | +18.30% | +18.07% |
| OCF margin | +33.91% | +50.65% | +24.65% | +15.17% | +20.38% | +19.55% | +20.11% | +19.97% |
| CapEx / Revenue | +4.06% | +2.69% | +1.30% | +1.20% | +2.14% | +1.58% | +1.52% | +1.56% |
| CapEx / D&A | 0.63 | 0.44 | 0.18 | 0.23 | 0.35 | — | — | — |
| Stock-based comp / Revenue | +2.12% | +1.32% | +0.90% | +0.89% | +0.91% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 0.90 | 1.45 | 1.24 | 1.22 | 1.39 | 1.47 | 1.90 | 2.11 |
| EPS · basic | 0.91 | 1.47 | 1.26 | 1.24 | 1.41 | 1.50 | 1.93 | 2.13 |
| Book value / share | 15.01 | 12.13 | 13.21 | 13.40 | 16.20 | 13.33 | 14.93 | 15.46 |
| Tangible BV / share | 10.38 | 7.84 | 8.97 | 9.17 | 11.71 | 13.33 | 14.93 | 15.46 |
| Sales / share | 4.73 | 5.43 | 7.34 | 8.10 | 8.30 | 7.47 | 8.25 | 8.68 |
| Operating CF / share | 1.60 | 2.75 | 1.81 | 1.23 | 1.69 | 1.46 | 1.66 | 1.73 |
| Free cash flow / share | 1.41 | 2.60 | 1.71 | 1.13 | 1.51 | 1.41 | 1.51 | 1.57 |
| Dividends / share | 0.58 | 0.61 | 0.61 | 0.61 | 0.60 | 0.59 | 0.62 | 0.66 |
| Payout ratio | +57.92% | +40.08% | +46.13% | +46.55% | +41.07% | +44.59% | +42.29% | +44.34% |
| Retention ratio | +42.08% | +59.92% | +53.87% | +53.45% | +58.93% | +55.41% | +57.71% | +55.66% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | +30.76% | +35.60% | +10.96% | +4.38% | -9.15% | +8.72% | +5.04% | +11.41% |
| Gross profit · YoY | — | +16.74% | -0.92% | +0.93% | +10.60% | -7.93% | +8.96% | +3.59% | +4.29% |
| Profit | |||||||||
| Operating income · YoY | — | +73.73% | -13.75% | +0.80% | +11.86% | -10.47% | +8.40% | +5.31% | +8.12% |
| EBITDA · YoY | — | +63.87% | -2.03% | -4.93% | -11.14% | +5.31% | +11.82% | +5.84% | +7.79% |
| Net income · YoY | — | +72.82% | -12.82% | -0.56% | +13.97% | -9.39% | +9.26% | +1.23% | +7.97% |
| Operating | |||||||||
| EBIT · YoY | — | +73.73% | -13.75% | +0.80% | +11.86% | -8.26% | +9.09% | +0.86% | +7.92% |
| R&D · YoY | — | — | — | — | — | — | — | — | — |
| Per-share | |||||||||
| EPS · diluted · YoY | — | +61.11% | -14.48% | -1.61% | +13.93% | +5.52% | +29.87% | +10.83% | +12.95% |
| EPS · basic · YoY | — | +61.54% | -14.29% | -1.59% | +13.71% | +6.45% | +28.58% | +10.42% | +12.93% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $7.44B | $11.71B | $13.01B | $16.57B | $18.48B | $15.4B | $16.35B | $17.9B |
| Net debt | $1.53B | $4.8B | $2.69B | $3.24B | $16.7B | $7.25B | $7.09B | $8.09B |
| Net debt / EBITDA | 0.77 | 1.48 | 0.85 | 1.07 | 6.21 | 2.56 | 2.24 | 2.42 |
| Debt / equity | 0.39 | 0.66 | 0.67 | 0.84 | 0.76 | 0.76 | 0.73 | 0.78 |
| Debt / assets | +4.28% | +6.40% | +6.87% | +8.11% | +8.21% | +7.67% | +7.56% | +7.83% |
| Equity / assets | +11.10% | +9.71% | +10.24% | +9.69% | +10.83% | +10.09% | +10.32% | +10.09% |
| Coverage | ||||||||
| EBITDA / interest expense | 22.27 | 4.67 | 0.92 | 0.66 | 0.62 | 0.71 | 0.74 | 0.74 |
| Operating income / interest | 17.88 | 3.97 | 0.69 | 0.53 | 0.62 | 0.60 | 0.61 | 0.60 |
| Interest expense | $89M | $696M | $3.48B | $4.58B | $4.32B | $3.98B | $4.28B | $4.54B |
| Liquidity | ||||||||
| Current ratio | 0.09 | 0.09 | 0.14 | 0.15 | 0.19 | — | — | — |
| Quick ratio | 0.09 | 0.09 | 0.14 | 0.15 | 0.19 | — | — | — |
| Cash ratio | 0.04 | 0.05 | 0.07 | 0.08 | 0.01 | — | — | — |
| Working capital | -$130.99B | -$135.72B | -$131.33B | -$137.8B | -$119.18B | — | — | — |
| Working capital / revenue | -2154.41% | -1707.17% | -1218.26% | -1152.10% | -954.62% | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).